Cargando…

It’s high time to turn the spotlight on HbSC disease

Detalles Bibliográficos
Autores principales:	Oluwole, Olubusola, Novelli, Enrico M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Inside Blood Advances
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362535/ https://www.ncbi.nlm.nih.gov/pubmed/37432698 http://dx.doi.org/10.1182/bloodadvances.2023009993

Ejemplares similares

Curing CLL: one clone at a time
por: Aslan, Burcu, et al.
Publicado: (2022)

Small but mighty: T-replete cords for myeloid disease
por: LaBelle, James L.
Publicado: (2023)

Cord blood power and the definition of success after BMT
por: Boelens, Jaap Jan, et al.
Publicado: (2022)

The sweet taste of liberalizing dietary restrictions in HCT
por: Peled, Jonathan U., et al.
Publicado: (2023)

Further evidence supporting the global use of hydroxyurea
por: Archer, Natasha M.
Publicado: (2023)

Blood stem cell grafts: frozen is fine, but fresh is best
por: Horwitz, Mitchell E.
Publicado: (2023)

More evidence for low-dose IL-2 for chronic GVHD in children
por: Levine, John E.
Publicado: (2023)

Diagnosing TMAs by automated red cell morphology analyses
por: Billett, Henny H., et al.
Publicado: (2023)

Peripheral megakaryocytes sound the alarm in COVID-19
por: Boilard, Eric, et al.
Publicado: (2023)

This CAR won’t start: predicting nonresponse in ALL
por: Webster, Jonathan A., et al.
Publicado: (2023)

Haplo ever after: haplo PTCy for children
por: Talano, Julie-An, et al.
Publicado: (2023)

Histidine-rich glycoprotein: antithrombosis without bleeding
por: Schmaier, Alvin H.
Publicado: (2023)

Natalizumab for GVHD: too little or too late?
por: Quann, Kevin, et al.
Publicado: (2023)

ADP: the missing link between thrombosis and hemolysis
por: Gerber, Gloria F., et al.
Publicado: (2023)

A wholesale approach to disarm multiple myeloma
por: Cenci, Simone
Publicado: (2023)

Autologous transplant and second malignancies in MM
por: Pasvolsky, Oren, et al.
Publicado: (2023)

On a collision course: SARS-CoV-2 variants and CAR T cells
por: Auletta, Jeffery J.
Publicado: (2023)

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
por: Qualls, David, et al.
Publicado: (2023)

ICANS prophylaxis: potentially transformative but elusive
por: Dowling, Mark R., et al.
Publicado: (2023)

HTLV-1 infection: role of CTL efficiency
por: Bangham, Charles R. M.
Publicado: (2008)

Most adults with severe HbSC disease are not treated with hydroxyurea
por: Ghunney, William Kwesi, et al.
Publicado: (2023)

HbSC Disease and Spontaneous Epidural Hematoma with Kernohan's Notch Phenomena
por: Yogarajah, Meera, et al.
Publicado: (2015)

Retinal thickness measurements in sickle cell patients with HbSS and HbSC genotype
por: Lim, Wei S., et al.
Publicado: (2018)

The Properties of Red Blood Cells from Patients Heterozygous for HbS and HbC (HbSC Genotype)
por: Hannemann, A., et al.
Publicado: (2011)

Sickle cell disease: A distinction of two most frequent genotypes (HbSS and HbSC)
por: da Guarda, Caroline Conceição, et al.
Publicado: (2020)

Genome wide association study of silent cerebral infarction in sickle cell disease (HbSS and HbSC)
por: Brewin, John N., et al.
Publicado: (2020)

Cation Homeostasis in Red Cells From Patients With Sickle Cell Disease Heterologous for HbS and HbC (HbSC Genotype)
por: Hannemann, A., et al.
Publicado: (2015)

Haemoglobin C Promotes Distinct Membrane Properties in Heterozygous HbSC red Cells
por: Clive Ellory, J.
Publicado: (2015)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

On the Inside
por: Minorsky, Peter V.
Publicado: (2021)

On the inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

The pleiotropic effects of α‐thalassemia on HbSS and HbSC sickle cell disease: Reduced erythrocyte cation co‐transport activity, serum erythropoietin, and transfusion burden, do not translate into increased survival
por: Brewin, John N., et al.
Publicado: (2022)

Searching for humanity in the time of COVID
por: Tandon, Suman, et al.
Publicado: (2020)

The management of venous thromboembolism in hospitalized patients with COVID-19
por: Spyropoulos, Alex C.
Publicado: (2020)

COVID-19 coagulopathy vs disseminated intravascular coagulation
por: Levi, Marcel
Publicado: (2020)

Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
por: Arruda, Valder R.
Publicado: (2021)

Doctor–patient relationship at the time of COVID-19: travel notes
por: Vallelonga, Fabrizio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0ul11fdkt1b9fmooibkk477gcc